Basel Medical (BMGL) Short term Debt (2024 - 2025)

Basel Medical recorded quarterly Short term Debt of $1.6 million in Q2 2025, up 355.02% quarter-over-quarter from $358128.0 in Q4 2024, and up 68.12% year-over-year from $969283.9 in Q2 2024.

Basel Medical's Short term Debt history runs 2 years deep, the most recent figure standing at $1.6 million for Q2 2025.

  • In Q2 2025, Short term Debt rose 68.12% year-over-year to $1.6 million; the TTM figure through Jun 2025 stood at $1.6 million (up 68.12% YoY), while the FY2025 annual figure was $1.6 million, up 68.12% from the prior year.
  • Short term Debt came in at $1.6 million for Q2 2025 at Basel Medical, up from $358128.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $1.6 million in Q2 2025 to a low of $358128.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 Basel Medical 8.57 Mn 6.23 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 1.63 Mn
Dec 31, 2024 358,128.00
Jun 30, 2024 969,283.92